Pain Assessment and Management in Oncological Practice: A Survey from the Italian Network of Supportive Care in Oncology

Overview

Journal Healthcare (Basel)

Specialty Health Services

Date 2025 Feb 13

PMID 39942401

Authors

Andrea Antonuzzo

Silvia Gonella

Livio Blasi

Simona Carnio

Ciro Franzese

Luigi Marano

Daniele Santini

Paolo Bossi

Affiliations

Soon will be listed here.

Abstract

Cancer pain is prevalent across all stages of the disease, significantly impacting patients' lives. Despite the availability of guidelines, its assessment and management remain suboptimal in many clinical settings. This study aimed to explore how healthcare professionals in Italy assess and manage cancer pain, identifying gaps and educational needs to improve adherence to best practices. A multidisciplinary Scientific Board designed an online survey comprising 28 items addressing demographics, pain assessment tools, perception of pain, pharmacological management, adverse effects, and barriers to care. The survey targeted oncologists, nurses, radiotherapists, and surgeons within the Italian Network of Supportive Care in Oncology. Data were collected from March to May 2024 and analyzed descriptively. Eighty-five professionals participated, predominantly oncologists (63.5%). Most respondents utilized pain scales, with the Numerical Rating Scale (60.3%) being the most frequent. However, specific tools like the Edmonton Symptom Assessment System (ESAS) were underutilized, possibly due to limited training and time constraints. Factors influencing analgesic choice included patient comorbidities (30.3%) and polypharmacy (28.0%). The main barriers to effective pain management included inadequate training (85.5%) and poor communication between patients and caregivers (40.6%) and within care teams (31.9%). Preventive measures for opioid-induced adverse events were widely employed, with laxatives (52.7%) and antiemetics (40.5%) being the most common. Findings underscore the need for structured training programs, improved communication, and integration of validated assessment tools. A multidisciplinary, proactive approach to cancer pain assessment and management is essential to optimize care and reduce its burden across all disease stages.

References

Glare P, Davies P, Finlay E, Gulati A, Lemanne D, Moryl N . Pain in cancer survivors. J Clin Oncol. 2014; 32(16):1739-47. PMC: 4031191. DOI: 10.1200/JCO.2013.52.4629. View

Liu W, Zheng Z, Tan K, Meredith G . Multidimensional Treatment of Cancer Pain. Curr Oncol Rep. 2017; 19(2):10. DOI: 10.1007/s11912-017-0570-0. View

Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M . Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4):iv166-iv191. DOI: 10.1093/annonc/mdy152. View

Cuomo A, Bimonte S, Forte C, Botti G, Cascella M . Multimodal approaches and tailored therapies for pain management: the trolley analgesic model. J Pain Res. 2019; 12:711-714. PMC: 6388734. DOI: 10.2147/JPR.S178910. View

Moro C, Brunelli C, Miccinesi G, Fallai M, Morino P, Piazza M . Edmonton symptom assessment scale: Italian validation in two palliative care settings. Support Care Cancer. 2005; 14(1):30-7. DOI: 10.1007/s00520-005-0834-3. View

Gjeilo K, Oksholm T, Follestad T, Wahba A, Rustoen T . Trajectories of Pain in Patients Undergoing Lung Cancer Surgery: A Longitudinal Prospective Study. J Pain Symptom Manage. 2019; 59(4):818-828.e1. DOI: 10.1016/j.jpainsymman.2019.11.004. View

Thong I, Jensen M, Miro J, Tan G . The validity of pain intensity measures: what do the NRS, VAS, VRS, and FPS-R measure?. Scand J Pain. 2018; 18(1):99-107. DOI: 10.1515/sjpain-2018-0012. View

Knaul F, Farmer P, Krakauer E, De Lima L, Bhadelia A, Kwete X . Alleviating the access abyss in palliative care and pain relief-an imperative of universal health coverage: the Lancet Commission report. Lancet. 2017; 391(10128):1391-1454. DOI: 10.1016/S0140-6736(17)32513-8. View

Truini A, Aleksovska K, Anderson C, Attal N, Baron R, Bennett D . Joint European Academy of Neurology-European Pain Federation-Neuropathic Pain Special Interest Group of the International Association for the Study of Pain guidelines on neuropathic pain assessment. Eur J Neurol. 2023; 30(8):2177-2196. DOI: 10.1111/ene.15831. View

10.

Paice J, Bohlke K, Barton D, Craig D, El-Jawahri A, Hershman D . Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline. J Clin Oncol. 2022; 41(4):914-930. DOI: 10.1200/JCO.22.02198. View

11.

Olver I, Keefe D, Herrstedt J, Warr D, Roila F, Ripamonti C . Supportive care in cancer-a MASCC perspective. Support Care Cancer. 2020; 28(8):3467-3475. DOI: 10.1007/s00520-020-05447-4. View

12.

Ripamonti C, Leporati R, De Feo G, Di Pede P, Toffolatti L, Guglielmo M . Italian version of the Edmonton Symptom Assessment System (ESAS)-Total Care (TC): development and psychometric validation in patients undergoing cancer treatment or follow-up. Support Care Cancer. 2021; 30(3):1923-1933. DOI: 10.1007/s00520-021-06594-y. View

13.

Larkin P, Cherny N, La Carpia D, Guglielmo M, Ostgathe C, Scotte F . Diagnosis, assessment and management of constipation in advanced cancer: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4):iv111-iv125. DOI: 10.1093/annonc/mdy148. View

14.

Bell T, Annunziata K, Leslie J . Opioid-induced constipation negatively impacts pain management, productivity, and health-related quality of life: findings from the National Health and Wellness Survey. J Opioid Manag. 2009; 5(3):137-44. DOI: 10.5055/jom.2009.0014. View

15.

Ayoub N, Jibreel M, Nuseir K, Al-Taani G . A Survey of Knowledge and Barriers of Healthcare Professionals toward Opioid Analgesics in Cancer Pain Management. Int J Clin Pract. 2022; 2022:1136430. PMC: 9159223. DOI: 10.1155/2022/1136430. View

16.

van den Beuken-van Everdingen M, Hochstenbach L, Joosten E, Tjan-Heijnen V, Janssen D . Update on Prevalence of Pain in Patients With Cancer: Systematic Review and Meta-Analysis. J Pain Symptom Manage. 2016; 51(6):1070-1090.e9. DOI: 10.1016/j.jpainsymman.2015.12.340. View

17.

Barbera L, Sutradhar R, Seow H, Mittmann N, Howell D, Earle C . The impact of routine Edmonton Symptom Assessment System (ESAS) use on overall survival in cancer patients: Results of a population-based retrospective matched cohort analysis. Cancer Med. 2020; 9(19):7107-7115. PMC: 7541161. DOI: 10.1002/cam4.3374. View

18.

Breivik H, Cherny N, Collett B, De Conno F, Filbet M, Foubert A . Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol. 2009; 20(8):1420-33. DOI: 10.1093/annonc/mdp001. View

19.

Cascella M, Vittori A, Petrucci E, Marinangeli F, Giarratano A, Cacciagrano C . Strengths and Weaknesses of Cancer Pain Management in Italy: Findings from a Nationwide SIAARTI Survey. Healthcare (Basel). 2022; 10(3). PMC: 8951760. DOI: 10.3390/healthcare10030441. View

20.

Caraceni A, Shkodra M . Cancer Pain Assessment and Classification. Cancers (Basel). 2019; 11(4). PMC: 6521068. DOI: 10.3390/cancers11040510. View